Align Technology stock underperforms as shares trade well below analyst targets
Published on 09/10/2026 at 17:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Align Technology stock (ISIN US0162551016) ended regular Nasdaq trading at USD 152.92 on September 9, 2026, reflecting a 0.37 percent decline from the previous close and leaving the clear-aligner specialist lagging the broader S&P 500.
Stock performance and market backdrop
According to data summarized by Ad-hoc-news, Align Technology stock closed at USD 152.92 on Nasdaq on September 9, 2026, implying a 0.37 percent loss for the session based on Nasdaq price data.
The same overview notes that the broader S&P 500 index finished down 0.6 percent and the Nasdaq 100 slipped 0.1 percent on September 9, 2026, meaning Align Technology underperformed the tech-focused benchmark despite a relatively modest absolute move.
Valuation gap versus analyst targets
As MarketBeat reports on September 10, 2026, Align Technology carries an average analyst rating of Moderate Buy, with one Strong Buy, eight Buy and six Hold recommendations and an average price target of USD 206.36.
Compared with the September 9, 2026 closing price of USD 152.92, that average target implies a gap of USD 53.44, indicating that analysts collectively see more than 30 percent upside potential from the latest trading level if their expectations are met.
Recent trading range and market capitalization
Market data compiled by Ad-hoc-news on September 9, 2026 shows Align Technology trading around USD 153.49 in recent sessions, with a documented 52-week range from USD 122.00 to USD 200.44 on Nasdaq.
Based on the same market snapshot, Align Technology’s market capitalization stood at about USD 11.0 billion in early September 2026, placing the company firmly in the mid-cap segment of the S&P 500 medical devices universe.
Risk and return profile for investors
Performance metrics presented in a recent overview on Yahoo Finance illustrate the mixed long-term picture for Align Technology stock as of September 9, 2026.
According to that analysis, Align Technology’s year-to-date return stood at minus 2.07 percent on September 9, 2026, compared with a positive 11.55 percent gain for the S&P 500 over the same period, underscoring the stock’s recent underperformance against the broader market.
The same table shows that over the trailing one-year period to September 9, 2026, Align Technology delivered a total return of plus 12.50 percent versus plus 17.25 percent for the S&P 500, while the three-year total return for Align Technology was negative 53.98 percent compared with a positive 71.32 percent for the index.
Upcoming conference appearance as a potential catalyst
In addition to valuation considerations, investors are watching upcoming events that may influence sentiment around Align Technology stock in the second half of September 2026.
As Ad-hoc-news relays from a Benzinga report dated September 8, 2026, Align Technology is scheduled to present at the Baird 2026 Global Healthcare Conference in New York on September 15, 2026, with a planned slot from 3:10 p.m. to 3:40 p.m. Eastern Time.
The conference appearance gives management a platform to update institutional investors on strategy and growth drivers in the clear-aligner and digital orthodontics market, and any new qualitative or quantitative guidance offered there could help narrow the gap between the current share price and analyst expectations.
Closing price and trading venue
Align Technology stock is listed on Nasdaq under the ticker ALGN, with the latest completed closing price of USD 152.92 on September 9, 2026 serving as the current reference level for investors evaluating the shares.
Align Technology stock - key facts
- Company: Align Technology, Inc.
- ISIN: US0162551016
- Ticker: ALGN
- Trading venue: Nasdaq
- Price (as of September 9, 2026, 4:00): 152.92 USD
- Market capitalization: 11.0 billion USD (as of September 9, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
